chemotherapy drug notes
TRANSCRIPT
-
8/8/2019 chemotherapy drug notes
1/6
Two types of chemotherapeutic agents:
1. Cell cycle specific drug will work on cells only in a certain phase2. Cell cycle nonspecific drug will work on cells in any phase or multiple phases at once.
Cell cycle specific drugs:
1. Antimetabolites: structural analogs of important natural metabolites.MOA mimic folic acid, pyrimidines, & purines and disrupt the cells ability to undergo DNA replication.
2 ways Falsely substituting purines, pyrimidines, or folic acidOR by inhibiting critical enzymes
DRUGS:
y Capecitabiney Fluorouracily Floxuridiney Fludarabiney Methotrexatey Cytarabiney Mercaptopuriney Thioguanine
Methotrexate: (folic acid analog)
Route: IV, IM, PO, intrathecal Uses: RA, cancer (breast, head & neck, renal, ovarian, bladder, testicular, lymphomas) AE: Photosensitivity, liver dysfunction, mucositis, myelosuppression (dec bone marrow activity) Guidelines for HighDoseMTX:
j Leucovorin rescue administer leucovorin to permit normal cells to synthesize importantcompounds needed for survival. SerumMTX must not exceed 5x10
-8. Monitor MTX levels every 12-
24 hrs. Failure to administer leucovorin at the right time/right dose can be fatal.
j Acute tumor lysis syndrome massive release of intracellular components. Can result in kidneyfailure, dysrhythmias, etc. Causes hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia
- Allopurinol (for uric acid) must be started several days before therapy begins- pH of urine must be above 7.0- If pH falls below 7.0, NaHCO3 is given (IVF and/or PO)- Bicitra (makes urine less acidic)
Fluorouracil: (pyrimidine analog)-c, t, u
Route: IV, IA, topical Uses: gastric, head & neck, breast cancers AE: alopecia, diarrhea, discoloration of veins, mucositis, myelosuppression Note: a derivation of this drug can be administered intrahepatically and is compatible with heparin
-
8/8/2019 chemotherapy drug notes
2/6
2. Mitotic Inhibitors:a. VincaAlkaloids
MOA: Act during M phase to prevent cell division.
DRUGS:
Vinblastine Vincristine (2mg/wk maximum) Vinorelbine
AE: vesicant agents, n/v, neurotoxic (foot drop, paralytic i leus, paresthesias), myelosuppression
b. Taxanes from the Pacific Yew treeMOA:similar to Vinca Alkaloids
DRUGS:
Paclitaxel SE: hypersensitivity rxns premedicate w/ steroid, antihistamine & H2 blocker; hair loss Docetaxel
AE: similar to Vinca Alkaloids
3. Topoisomerase 1 Inhibitors:MOA: kill cells in S phase. Inhibits enzyme Topoisomerase 1; (makes single-stranded cuts in DNA preventing
replication)
DRUGS:
Irinotecan (severe diarrhea give atropine) Topotecan (diarrhea) Etoposide PO, IV (hypotension, bronchospasm) monitor BP closely
Cell Cycle NonspecificDrugs:
1. Alkylating Agents:MOA: interfere with chemical structure of DNA; alkyl group attaches to nucleic acid instead of H+
DRUGS:
Nitrogen mustard Chlorambucil Cyclophosphamide Ifosfamide Busulfan Carboplatinum
Cisplatinum Thiotepa
Cyclophosphamide:
Route: PO, IV Uses: chronic leukemia, ovarian, breast, HD & NH lymphomas, multiple myeloma AE: hemorrhagic cystitis (admin early in the day, need hydration, assess urine for blood, void frequently
esp before bed); sterility; n/v; myelosuppression; cardiotoxic (at high doses)
Cisplatin:
-
8/8/2019 chemotherapy drug notes
3/6
Route: IV AE: nephrotoxic (I&O, hydration, Cr & BUN, Mannitol); peripheral neuropathy; electrolyte imbalance
(Mg & K, may be admin these in IVF); ototoxic (high freq audiograms); very emetogenic
Nitrosoureas: unique b/c they cross bbb; can be used to treat brain tumors.
Carmustine: PO, IV
Lomustine: PO, IV
2. Antitumor Antibiotics:MOA: act either by alkylation process or intercalation process insertion of drug btw 2 strands of DNA to block
synthesis; (anthracyclines subgroup works by intercalation)
DRUGS: (inanthracyclines group):
Daunorubicin Doxorubicin Idarubicin
Doxorubicin:
AE: red skin, vesicant, cardiotoxic (baseline & periodic ECHOs), hair loss DOSE: max accumulative dose 550mg/m2
Dexrazoxane:
Bleomycin:
AE: pulmonary toxicity (baseline PFTs); anaphylaxis (give test dose) CI: contraindicated in people over 70 only drug inthis category that is nota vesicant
AE: (of all antitumor antibiotics): Vesicants!
- Check for blood return every 2-3 ccs (ifIVP)- If admin via CVC, verify blood return w/ 2ndRN before starting check every 4 hrs- Stop infusion if pain, redness, or infiltration call MD
3. Miscellaneous Agents:DRUGS:
y Asparaginase IV; 2nd line for acute lymphocytic leukemia; give test dose each time (anaphylaxis)y Hydroxyurea PO; certain solid tumors, CML, sickle cell, AIDS; bone marrow toxicity occurs w/in one
week of starting
-
8/8/2019 chemotherapy drug notes
4/6
HORMONES MOA AE USES
Interfere w/ protein
synthesis or rec blockade
Less toxic than
antineoplastic agents
Antiestrogens
Tamoxifen Approved for breast cancer
prevention (in high risk pts)
Hot flashes; risk for DVT; HA Used in postmenopausal
women w/ breast cancer
Aromatase Inhibitors Inhibits enzyme from
Anastrozole converting androgens intoestrogen
Osteoporosis In postmenopausal womenw/ breast cancer
Progestins
Megestrol To manage cachexia in
advanced AIDS & cancer
Palliation for women w/
endometrial cancer
**General side effects for all chemo drugs: They all affect rapidly dividing cell types to a degree hair follicles,
myelosuppression (leukopenia, neutropenia, thrombocytopenia, anemia), GI mucosa, & reproductive organs.
-
8/8/2019 chemotherapy drug notes
5/6
Immunomodulating Agents: (Interferons, Interleukins, CSFs)
Interferons:
Classification Antiviral & antineoplastic
MOA (brief) Directly inhibits effects on DNA & protein synthesis & inc cancer cell Ag on cell surface (enables
immune sys to recognize cancer cells more easily); stop virus replication, stop penetration into
healthy cells, enhance actions of immune sys cells, and stop division of cancer cellsAdverse Effects Fever, chills, HA, malaise, myalgia, fatigue; n/v, diarrhea, anorexia; paranoia, dizziness,
confusion; tachycardia; neutropenia, thrombocytopenia; inc BUN & Cr; depression, suicidal
When is it used? Viruses: rhinovirus, retrovirus, papillovirus, hep C, condyloma. Cancers: Kaposi sarcoma,
multiple myeloma, renal cell carcinoma, bladder cancer. Autoimmune:MS
Lab considerations CBC, renal fcn; vital signs @ ea visit; Tylenol for flu s/s;
Nursing
considerations
Teach about fever patterns. Watch for depression & suicidal ideation.
Interleukins:
MOA Enhances multiplication of NK cells, which recognize cancer cells as non-self. Also inc
production ofB lymphocytes.
Adverse Effects Capillary leak syndrome (severe toxicity)-hypotension, pulmonary edema; fluid retention can
lead to CHF, arrhythmias, MI; fever, chills, rash, fatigue, HA, myalgias
Drug Interactions DO NOT GIVE DIURETICS
When is it used? Renal cell carcinoma, malignant melanoma, colorectal cancer, limited use in HD
Nursing
considerations
Monitor fluid balance, I&O, wt gain, edema; treat flu s/s w/ tylenol
Colony
Stimulating
Factors
MOA Complex network of glycoprotein hormones responsible for the differentiation, proliferation,
maturation, & functional activity of hematopoietic cells
Subtypes: Granulocyte CSF:
y Filgrastim, Pegfilgrastim, & SargramostimErythropoietin:
y Epoetin-alphaThrombopoiesis:
y OprelvekinUses: Dec chemo-induced myelosuppression; stimulate hematopoiesis in marrow failure; promote
cellular differentiation; support peripheral stem cell harvesting; enhance antibiotic therapy
Route: SQ; must teach family how to give; given until reach parameter set by practitioner (i.e. wbc >
3000)
-
8/8/2019 chemotherapy drug notes
6/6